Exvastat: The remarkable potential of re-profiled drugs

Commercializing deep tech startups: A practical guide for founders and investors

Miles Kirby, CEO, Deeptech Labs, talks to Carol Cheung about the launch of DTL and how they’re a different type of accelerator filling an important gap between seed and series A

“Innovation is not a straight line to success”

Andrew Williamson, Managing Partner of CIC and Ian Jauncey, our new Operating…

“I was told I’d never make money” — Dr Tom Waver, CO Founder & CEO, PetMedix

The UK CFIUS regime — what you need to know

Five emerging tech trends and how to stay on top

Clive Cox, CTO, Seldon

Clive Cox, CTO explains how Seldon are solving a complex yet fundamental…

What does Cambridge need to do to maintain its position at the forefront? And are UK companies selling out too soon…

Jason Mellad, CEO of Start Codon, talks to Michael Anstey about what makes an accelerator versus a stagnator